OKRA has announced the appointment of Marshall Pillay as VP Commercial – Europe and International. Marshall has joined OKRA from AKTANA, where he was most recently GM of Europe, responsible for all business and operations in the continent.
Previously, Marshall has also held director positions at Ernst & Young and IMS health, where he specialised in commercial excellence, data, analytics and SaaS-based solutions for Life Sciences.
Marshall joins OKRA as the company is experiencing significant growth across the sector. The OKRA team are bringing their AI vision to life with key client partnerships across commercial, medical and market access, supporting Life Science companies to be fit and ready for a post COVID world.
Dr Loubna Bouarfa, CEO and Founder of OKRA said: “I’m delighted that Marshall is joining OKRA to further expand our European and global presence and implement our best in-class AI solutions for all Life Sciences. His international experience in scaling enterprise-wide solutions for Pharma will be invaluable for OKRA’s next chapter.”
Speaking about his new appointment, Marshall Pillay said: “It’s very clear to me where the future is, in the new world post COVID, Life Sciences require new products to help drive outcomes and OKRA definitely has the suite of scalable solutions Pharma companies have been looking for! Having seen the products first-hand, there is no doubt in my mind that OKRA has the technology to make a huge impact worldwide for both Large Pharma and SMEs.”